Historical salary details - Mr. Michael Lisjak, Chief Regulatory Officer and Senior Vice President, Business Development, Cyclo Therapeutics Inc - Ordinary Shares - Class A
Mr. Michael Lisjak has been the Chief Regulatory Officer and Senior Vice President, Business Development of Cyclo Therapeutics Inc - Ordinary Shares - Class A since 31 Jul 2019 and his latest salary was 473.2 K. View his historical salary.
Mr. Michael Lisjak
Chief Regulatory Officer and Senior Vice President, Business Development
$ 473.2 K
Gross Remuneration
-
Current Company
Cyclo Therapeutics Inc - Ordinary Shares - Class A
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2023 | Cyclo Therapeutics Inc - Ordinary Shares - Class A | Chief Regulatory Officer and Senior Vice President, Business Development | 473.2 K | -18.8 % |
| 2022 | Cyclo Therapeutics Inc - Ordinary Shares - Class A | Chief Regulatory Officer and Senior Vice President, Business Development | 582.7 K | -7.7 % |
| 2021 | Cyclo Therapeutics Inc - Ordinary Shares - Class A | - | 631.0 K | - |
| 2021 | Cyclo Therapeutics Inc - Ordinary Shares - Class A | Chief Regulatory Officer and Senior Vice President, Business Development | 631.0 K | - |
| 2020 | Cyclo Therapeutics Inc - Ordinary Shares - Class A | - | 299.4 K | - |
| 2020 | Cyclo Therapeutics Inc - Ordinary Shares - Class A | - | 299.4 K | - |
| 2020 | Cyclo Therapeutics Inc - Ordinary Shares - Class A | Chief Regulatory Officer and Senior Vice President, Business Development | - | - |
| 2019 | Cyclo Therapeutics Inc - Ordinary Shares - Class A | Chief Regulatory Officer and Senior Vice President, Business Development | - | - |